As a boarder at Launceston Boys' Grammar School in Tasmania, David Warren tinkered with the machine after lessons, learning what made it work. He charged friends a penny to listen to cricket ...

However, the Grey Market Premium (GMP) for Hyundai Motors indicates a downward trend ahead of its listing next Tuesday, potentially leading to a flat debut. This means that the estimated listing ...

A former employee of a U.S. Army facility in Warren is facing a federal charge in connection with threats made towards ...

Now Greater Manchester Police (GMP) has confirmed the search for Mr Daniels has come to an end after the discovery tonight. The force said his death is not being treated as suspicious and ...

Sorry, we can’t find any flight deals flying from Gimpo International to David right now.Find a flight How did we find these deals? The deals you see here are the ...

In the meantime, Hyundai Motor India's GMP (grey market premium) also witnessed significant volatility, nosediving heavily before the issue's close. After plunging to a negative Rs 32 on the day ...

The Grey Market Premium (GMP) currently stands at ₹75, indicating an estimated listing price of ₹2,035 per share, potentially ...

The SME IPO of Premium Plast opened for subscription today and will close on October 23. The company aims to raise Rs 26 crore through the SME IPO and list the shares on the NSE SME platform.

Hyundai's IPO saw a revival in its grey market premium to 5%, indicating positive investor sentiment. Trading at Rs 2,067 in the grey market, the stock is expected to debut with gains on October 22.

Today (Thursday, October 17) is the last day of the issue's subscription. The current grey market premium (GMP) of Hyundai ...

The current grey market premium (GMP) of the issue indicates shares of the company could be listed at a solid premium of over 96 per cent. 2. Lakshya Powertech IPO date: The issue opened for ...

We also continue to make steady progress on our GMP manufacturing facility, which remains on track and will come online in 2025. Additionally, over the past year, we have built our translational ...